Cardiovascular disease is the leading contributor to years lost due to disability or premature
death among adults. Current efforts focus on risk prediction and risk factor mitigation ‚which …

The following position statement is the second update by the American Society for Metabolic
and Bariatric Surgery (ASMBS) on prophylactic measures for reducing the risk of venous …

By January 2022 over ten billion doses of COVID-19 vaccines had been administered
worldwide. Concerns about COVID-19 vaccine-associated thrombosis arose after the …

Continuous advances in prehabilitation research over the past several decades have
clarified its role in improving preoperative risk factors, yet the evidence demonstrating …

Background: Early during the course of the ongoing COVID-19 pandemic, reports suggested
alarmingly high incidences for thromboembolic events in critically ill patients with COVID-19 …

Background Venous thromboembolism (VTE) remains the third leading cause of acute
cardiovascular syndrome following myocardial infarction and ischemic stroke. The global …

Background Venous thromboembolism (VTE) is a prevalent disease with high morbidity and
mortality. VTE has well‐documented physical sequelae; however, the psychological and …

BACKGROUND: Venous thromboembolism (VTE) is a major cause of morbidity and
mortality worldwide. Current risk assessment tools, such as the Caprini and Padua scores …

Background Venous thrombotic events (VTE) are frequent in COVID-19, and elevated
plasma D-dimer (pDd) and dyspnea are common in both entities. Objective To determine the …

Venous thromboembolism (VTE) is a common condition that can recur, leading to multiple
therapeutic strategies to prevent it. The aim of this study was to explore the clinical efficacy of …